SEARCH

SEARCH BY CITATION

References

  • Allinson T. M., Parkin E. T., Turner A. J. and Hooper N. M. (2003) ADAMs family members as amyloid precursor protein alpha-secretases. J. Neurosci. Res. 74, 342352.
  • Amador F. C., Henriques A. G., Da Cruz E. S. O. A. and Da Cruz E. S. E. F. (2004) Monitoring protein phosphatase 1 isoform levels as a marker for cellular stress. Neurotoxicol. Teratol. 26, 387395.
  • Black M. M. and Keyser P. (1987) Acetylation of alpha-tubulin in cultured neurons and the induction of alpha-tubulin acetylation in PC12 cells by treatment with nerve growth factor. J. Neurosci. 7, 18331842.
  • Black M. M., Baas P. W. and Humphries S. (1989) Dynamics of alpha-tubulin deacetylation in intact neurons. J. Neurosci. 9, 358368.
  • Bloom K. (2004) Microtubule composition: cryptography of dynamic polymers. Proc. Natl Acad. Sci. USA 101, 68396840.
  • Brewer G. J., Torricelli J. R., Evege E. K. and Price P. J. (1993) Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J. Neurosci. Res. 35, 567576.
  • Buxbaum J. D., Liu K. N., Luo Y., Slack J. L., Stocking K. L., Peschon J. J., Johnson R. S., Castner B. J., Cerretti D. P. and Black R. A. (1998) Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 273, 2776527767.
  • Carlson C. D., Czilli D. L. and Gitter B. D. (2000) Regulation of amyloid precursor protein processing by Abeta in human glioma cells. Neurobiol. Aging 21, 747756.
  • Cras P., Kawai M., Lowery D., Gonzalez-DeWhitt P., Greenberg B. and Perry G. (1991) Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. Proc. Natl Acad. Sci. USA 88, 75527556.
  • Davis-Salinas J., Saporito-Irwin S. M., Cotman C. W. and Van Nostrand W. E. (1995) Amyloid beta-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells. J. Neurochem. 65, 931934.
  • Dompierre J. P., Godin J. D., Charrin B. C., Cordelieres F. P., King S. J., Humbert S. and Saudou F. (2007) Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington’s disease by increasing tubulin acetylation. J. Neurosci. 27, 35713583.
  • Ekinci F. J. and Shea T. B. (2000) Beta-amyloid-induced tau phosphorylation does not correlate with degeneration in cultured neurons. J. Alzheimers Dis. 2, 715.
  • Esler W. P., Kimberly W. T., Ostaszewski B. L., Ye W., Diehl T. S., Selkoe D. J. and Wolfe M. S. (2002) Activity-dependent isolation of the presenilin- gamma -secretase complex reveals nicastrin and a gamma substrate. Proc. Natl Acad. Sci. USA 99, 27202725.
  • Gandy S., Caporaso G., Buxbaum J., Frangione B. and Greengard P. (1994) APP processing, A beta-amyloidogenesis, and the pathogenesis of Alzheimer’s disease. Neurobiol. Aging 15, 253256.
  • Gardiner J., Barton D., Marc J. and Overall R. (2007) Potential role of tubulin acetylation and microtubule-based protein trafficking in familial dysautonomia. Traffic 8, 11451149.
  • Glenner G. G. and Wong C. W. (1984) Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885890.
  • Goedert M., Spillantini M. G., Cairns N. J. and Crowther R. A. (1992) Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 8, 159168.
  • Gunawardena S. and Goldstein L. S. (2001) Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila. Neuron 32, 389401.
  • Hamm-Alvarez S. F. and Sheetz M. P. (1998) Microtubule-dependent vesicle transport: modulation of channel and transporter activity in liver and kidney. Physiol. Rev. 78, 11091129.
  • Hardy J. A. and Higgins G. A. (1992) Alzheimer’s disease: the amyloid cascade hypothesis. Science 256, 184185.
  • Hardy J. and Selkoe D. J. (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297, 353356.
  • Henriques A. G., Vieira S. I., Rebelo S., Domingues S. C., Da Cruz e Silva E. F. and Da Cruz e Silva O. A. (2007) Isoform specific amyloid-beta protein precursor metabolism. J. Alzheimers Dis. 11, 8595.
  • Henriques A. G., Vieira S. I., Da Cruz E. S. E. F. and Da Cruz E. S. O. A. (2009a) Alphabeta hinders nuclear targeting of AICD and Fe65 in primary neuronal cultures. J. Mol. Neurosci. 39, 248255.
  • Henriques A. G., Vieira S. I., Crespo-Lopez M. E., Guiomar de Oliveira M. A., Da Cruz e Silva E. F. and Da Cruz e Silva O. A. (2009b) Intracellular sAPP retention in response to Abeta is mapped to cytoskeleton-associated structures. J. Neurosci. Res. 87, 14491461.
  • Hiruma H., Katakura T., Takahashi S., Ichikawa T. and Kawakami T. (2003) Glutamate and amyloid beta-protein rapidly inhibit fast axonal transport in cultured rat hippocampal neurons by different mechanisms. J. Neurosci. 23, 89678977.
  • Hyman B. T., Van Hoesen G. W., Damasio A. R. and Barnes C. L. (1984) Alzheimer’s disease: cell-specific pathology isolates the hippocampal formation. Science 225, 11681170.
  • Inomata H., Nakamura Y., Hayakawa A., Takata H., Suzuki T., Miyazawa K. and Kitamura N. (2003) A scaffold protein JIP-1b enhances amyloid precursor protein phosphorylation by JNK and its association with kinesin light chain 1. J. Biol. Chem. 278, 2294622955.
  • Ittner L. M., Ke Y. D. and Gotz J. (2009) Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease. J. Biol. Chem. 284, 2090920916.
  • Kang J., Lemaire H. G., Unterbeck A., Salbaum J. M., Masters C. L., Grzeschik K. H., Multhaup G., Beyreuther K. and Muller-Hill B. (1987) The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733736.
  • Lammich S., Kojro E., Postina R., Gilbert S., Pfeiffer R., Jasionowski M., Haass C. and Fahrenholz F. (1999) Constitutive and regulated alpha-secretase cleavage of Alzheimer’s amyloid precursor protein by a disintegrin metalloprotease. Proc. Natl Acad. Sci. USA 96, 39223927.
  • Lanzetti L. (2007) Actin in membrane trafficking. Curr. Opin. Cell Biol. 19, 453458.
  • Lazarov O., Morfini G. A., Lee E. B. et al. (2005) Axonal transport, amyloid precursor protein, kinesin-1, and the processing apparatus: revisited. J. Neurosci. 25, 23862395.
  • Lee S. F., Shah S., Li H., Yu C., Han W. and Yu G. (2002) Mammalian APH-1 interacts with presenilin and nicastrin and is required for intramembrane proteolysis of amyloid-beta precursor protein and Notch. J. Biol. Chem. 277, 4501345019.
  • Li Y. M., Lai M. T., Xu M., Huang Q., DiMuzio-Mower J., Sardana M. K., Shi X. P., Yin K. C., Shafer J. A. and Gardell S. J. (2000) Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state. Proc. Natl Acad. Sci. USA 97, 61386143.
  • Masliah E., Mallory M., Hansen L., Alford M., Albright T., DeTeresa R., Terry R., Baudier J. and Saitoh T. (1991) Patterns of aberrant sprouting in Alzheimer’s disease. Neuron 6, 729739.
  • Matsuda S., Matsuda Y. and D’Adamio L. (2003) Amyloid beta protein precursor (AbetaPP), but not AbetaPP-like protein 2, is bridged to the kinesin light chain by the scaffold protein JNK-interacting protein 1. J. Biol. Chem. 278, 3860138606.
  • Mendoza-Naranjo A., Gonzalez-Billault C. and Maccioni R. B. (2007) Abeta1-42 stimulates actin polymerization in hippocampal neurons through Rac1 and Cdc42 Rho GTPases. J. Cell Sci. 120, 279288.
  • Meyer D. I. and Burger M. M. (1979) The chromaffin granule surface: the presence of actin and the nature of its interaction with the membrane. FEBS Lett. 101, 129133.
  • Michaelis M. L., Ranciat N., Chen Y., Bechtel M., Ragan R., Hepperle M., Liu Y. and Georg G. (1998) Protection against beta-amyloid toxicity in primary neurons by paclitaxel (Taxol). J. Neurochem. 70, 16231627.
  • Michaelis M. L., Ansar S., Chen Y., Reiff E. R., Seyb K. I., Himes R. H., Audus K. L. and Georg G. I. (2005) {beta}-Amyloid-induced neurodegeneration and protection by structurally diverse microtubule-stabilizing agents. J. Pharmacol. Exp. Ther. 312, 659668.
  • Potokar M., Kreft M., Li L., Daniel Andersson J., Pangrsic T., Chowdhury H. H., Pekny M. and Zorec R. (2007) Cytoskeleton and vesicle mobility in astrocytes. Traffic 8, 1220.
  • Reed N. A., Cai D., Blasius T. L., Jih G. T., Meyhofer E., Gaertig J. and Verhey K. J. (2006) Microtubule acetylation promotes kinesin-1 binding and transport. Curr. Biol. 16, 21662172.
  • Salinero O., Moreno-Flores M. T., Ceballos M. L. and Wandosell F. (1997) beta-Amyloid peptide induced cytoskeletal reorganization in cultured astrocytes. J. Neurosci. Res. 47, 216223.
  • Schmitt T. L., Steiner E., Trieb K. and Grubeck-Loebenstein B. (1997) Amyloid beta-protein(25-35) increases cellular APP and inhibits the secretion of APPs in human extraneuronal cells. Exp. Cell Res. 234, 336340.
  • Sennvik K., Bogdanovic N., Volkmann I., Fastbom J. and Benedikz E. (2004) Beta-secretase-cleaved amyloid precursor protein in Alzheimer brain: a morphologic study. J. Cell Mol. Med. 8, 127134.
  • Seyb K. I., Ansar S., Bean J. and Michaelis M. L. (2006) beta-Amyloid and endoplasmic reticulum stress responses in primary neurons: effects of drugs that interact with the cytoskeleton. J. Mol. Neurosci. 28, 111123.
  • Steiner H., Winkler E., Edbauer D., Prokop S., Basset G., Yamasaki A., Kostka M. and Haass C. (2002) PEN-2 is an integral component of the gamma-secretase complex required for coordinated expression of presenilin and nicastrin. J. Biol. Chem. 277, 3906239065.
  • Stokin G. B., Lillo C., Falzone T. L. et al. (2005) Axonopathy and transport deficits early in the pathogenesis of Alzheimer’s disease. Science 307, 12821288.
  • Takahashi R. H., Almeida C. G., Kearney P. F., Yu F., Lin M. T., Milner T. A. and Gouras G. K. (2004) Oligomerization of Alzheimer’s beta-amyloid within processes and synapses of cultured neurons and brain. J. Neurosci. 24, 35923599.
  • Terry R. D., Masliah E., Salmon D. P., Butters N., DeTeresa R., Hill R., Hansen L. A. and Katzman R. (1991) Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572580.
  • Thornton E., Vink R., Blumbergs P. C. and Van Den Heuvel C. (2006) Soluble amyloid precursor protein alpha reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats. Brain Res. 1094, 3846.
  • Town T., Zolton J., Shaffner R. et al. (2002) p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitro. J. Neurosci. Res. 69, 362372.
  • Turner P. R., O’Connor K., Tate W. P. and Abraham W. C. (2003) Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog. Neurobiol. 70, 132.
  • Vassar R., Bennett B. D., Babu-Khan S. et al. (1999) Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735741.
  • Vintem A. P., Henriques A. G., Da Cruz E. S. O. A. and Da Cruz E. S. E. F. (2009) PP1 inhibition by Abeta peptide as a potential pathological mechanism in Alzheimer’s disease. Neurotoxicol. Teratol. 31, 8588.
  • Yan R., Han P., Miao H., Greengard P. and Xu H. (2001) The transmembrane domain of the Alzheimer’s beta-secretase (BACE1) determines its late Golgi localization and access to beta -amyloid precursor protein (APP) substrate. J. Biol. Chem. 276, 3678836796.